CRISPR Technology

Revolutionizing the Way CRISPR is Used in Plants

Next-generation genomics achieves morphine pathway removal for poppy cultivation and drug development.

Our Science

Employing our patent on vernalization-induced flowering (AU 2020101437) together with CRISPR technology and cutting-edge farming practices, Emerzene has developed a non-addictive strain of poppy.

We are developing a morphine-free source of thebaine for pharmaceutical manufacture to be part of the solution to drug abuse and dependence.

What is CRISPR?

Born to solve global food crisis’, plant disease problems, and world-wide agricultural challenges, Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR) genome-editing technology opens new opportunities to engineer disease resistant cultivation and solve major challenges in crop improvement.

CRISPR technology has been successfully used to engineer plants and crops resistant to bacteria, viruses, fungi, and pests. Through disrupting, deleting, correcting, and inserting genomes with desired traits, CRISPR technology enables development and improvement of critical crops characteristics.

PARTNER WITH US

A Specific, Efficient and Versatile Tool for Editing Genes

Through disrupting, deleting, correcting, and inserting genomes with desired traits, CRISPR technology is able to develop crops that contain all critical characteristics.

CRISPR Applied to Plant-Based Medicine

Searching for a breakthrough in pain relief, Emerzene experts utilized CRISPR mediated genome editing to engineer a unique strain of poppy (P. Bracteatum).

Key advantages include:

The traditional poppy plant is seasonal, requiring annual planting and cultivation. Our unique strain is perennial, thereby reducing management processes, resulting in lower costs and minimizing environmental disruptions.
Thanks to CRISPR technology, Papaver bracteatum is not recorded as a host of either downy mildew of opium poppy. A controlled inoculation trial is scheduled. This diminishes or eliminates the need for chemical or cultural control measures.
By selecting desired traits within the poppy plant, and utilizing CRIPSR technology to modify genomes within the plant, Our crop yields thebaine, a controlled alkaloid and the starting material for both opioid analgesics and the antagonists that reverse them.
Our extraction is water-based, avoiding the organic solvents conventional processing requires, maximizing extraction and production of all natural chemical free extracts.

Key advantages include:

The traditional poppy plant is seasonal, requiring annual planting and cultivation. Our unique strain is perennial, thereby reducing management processes, resulting in lower costs and minimizing environmental disruptions.
Thanks to CRISPR technology, P bracteatum poppy strain is resistant to diseases that plague normal poppy plantations. This diminishes or eliminates the need for chemical or cultural control measures.
By selecting desired traits within the poppy plant, and utilizing CRIPSR technology to modify genomes within the plant, we can produce a complete non-addictive form of poppy extract without a morphine pathway.
Our extraction methods use water, in palace of chemicals, maximizing extraction and production all natural chemical free extracts.

Our API manufacturing

is being contracted to an established GMP certified facility in Liechtenstein, Europe.

We are actively looking to partner with pharmaceutical companies for our R&D trials to propel the next generation of medicinal advances.

The traditional poppy plant is seasonal, requiring annual planting and cultivation. Our unique strain is perennial, thereby reducing management processes, resulting in lower costs and minimizing environmental disruptions.

Thanks to CRISPR technology, Papaver bracteatum is not recorded as a host of either downy mildew of opium poppy. A controlled inoculation trial is scheduled. This diminishes or eliminates the need for chemical or cultural control measures.

By selecting desired traits within the poppy plant, and utilizing CRIPSR technology to modify genomes within the plant, Our crop yields thebaine, a controlled alkaloid and the starting material for both opioid analgesics and the antagonists that reverse them.

Our extraction is water-based, avoiding the organic solvents conventional processing requires, maximizing extraction and production of all natural chemical free extracts.

The traditional poppy plant is seasonal, requiring annual planting and cultivation. Our unique strain is perennial, thereby reducing management processes, resulting in lower costs and minimizing environmental disruptions.

Thanks to CRISPR technology, P bracteatum poppy strain is resistant to diseases that plague normal poppy plantations. This diminishes or eliminates the need for chemical or cultural control measures.

By selecting desired traits within the poppy plant, and utilizing CRIPSR technology to modify genomes within the plant, we can produce a complete non-addictive form of poppy extract without a morphine pathway.

Our extraction methods use water, in palace of chemicals, maximizing extraction and production all natural chemical free extracts.